SCHEMBL4446544

SCHEMBL4446544

CO[Si](CCCCCCCN)(OC)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 9/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA3 P07451 2/20 0.42
CA4 P22748 2/20 0.42
CA6 P23280 2/20 0.42
CA5A P35218 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA5B Q9Y2D0 2/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 2/20 0.42
BLM P54132 1/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EPHX1 P07099 1/20 0.39
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013358 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4530728 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4527154 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4516171 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4539375 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4538853 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL126870 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4535614 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL483098 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3
SCHEMBL4539329 1.00 DNM1 (0.42) DNM1CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015646-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY MURATA MANUFACTURING CO (JP) 2026-01-15 US disclosed
WO-2024209808-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIOBATTERY 株式会社村田製作所 2024-10-10 WO disclosed
CN-118406079-A Modified silane coupling agent and preparation method and application thereof 派迈新材料(成都)有限责任公司 2024-07-30 CN disclosed
US-12037432-B2 Method for preparing modified and conjugated diene-based polymer and modified and conjugated diene-based polymer prepared using the same LG CHEM, LTD. (KR) 2024-07-16 US disclosed
US-12037432-B2 Method for preparing modified and conjugated diene-based polymer and modified and conjugated diene-based polymer prepared using the same LG CHEM, LTD. (KR) 2024-07-16 US disclosed
CN-117616088-A Mica particles 伊梅斯切公司 2024-02-27 CN disclosed
CN-117425690-A Talc particles 伊梅斯切公司 2024-01-19 CN disclosed
US-20230303404-A1 NANOPARTICLES, DISPERSION OF NANOPARTICLES, AND PRODUCTION METHOD OF NANOPARTICLES TOKYO OHKA KOGYO CO., LTD. (JP) 2023-09-28 US disclosed
US-20230242692-A1 COMPOSITION AND CURED PRODUCT TOKYO OHKA KOGYO CO., LTD. (JP) 2023-08-03 US disclosed
CN-116514161-A Nanoparticle, nanoparticle dispersion liquid, and method for producing nanoparticle 东京应化工业株式会社 2023-08-01 CN disclosed
US-20070185239-A1 Crosslinkable elastomeric composition and tire for vehicle wheels comprising the same PIRELLI & C. S.P.A. (IT) 2007-08-09 US disclosed
WO-2007019478-A2 DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-02-15 WO disclosed
EP-1697150-A1 CROSSLINKABLE ELASTOMERIC COMPOSITION AND TIRE FOR VEHICLE WHEELS COMPRISING THE SAME Pirelli & C. S.p.A. (IT) 2006-09-06 EP disclosed
WO-2005058615-A1 CROSSLINKABLE ELASTOMERIC COMPOSITION AND TIRE FOR VEHICLE WHEELS COMPRISING THE SAME PIRELLI & C. S.P.A. (IT) 2005-06-30 WO disclosed
EP-1339539-B9 PROCESS FOR MANUFACTURING, MOULDING AND CURING TYRES FOR VEHICLES WHEELS PIRELLI (IT) 2005-06-15 EP disclosed
EP-1339539-B1 PROCESS FOR MANUFACTURING, MOULDING AND CURING TYRES FOR VEHICLES WHEELS PIRELLI (IT) 2005-01-19 EP disclosed
US-20040094252-A1 Process for manufacturing, moulding and curing tyres for vehicles wheels PIRELLI PNEUMATICI S.P.A. (IT) 2004-05-20 US disclosed
EP-1339539-A1 PROCESS FOR MANUFACTURING, MOULDING AND CURING TYRES FOR VEHICLES WHEELS PIRELLI PNEUMATICI Società per Azioni (IT) 2003-09-03 EP disclosed
WO-2002045942-A1 PROCESS FOR MANUFACTURING, MOULDING AND CURING TYRES FOR VEHICLES WHEELS PIRELLI PNEUMATICI S.P.A (IT) 2002-06-13 WO disclosed
EP-0498458-A2 Novel aminoalkyl alkoxy silane compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015646-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY SORD, NQO1, PDHB DNM1 3957/4885CA12 209/4885CA1 311/4885
US-20230303404-A1 NANOPARTICLES, DISPERSION OF NANOPARTICLES, AND PRODUCTION METHOD OF NANOPARTICLES CD63, NIBAN2, ZRANB2 DNM1 463/4885CA12 944/4885CA1 2285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.